You are here:
Gavi’s two funding streams, innovative finance and direct contributions account for 33% and 67% respectively of the Vaccine Alliance’s overall funding portfolio.
Multi-year pledges and commitments are crucial to sustaining Gavi's ongoing programmes and its ability to fund new vaccines.
Public-private partnerships Corporations, private individuals & foundations play a vital role in meeting Gavi needs, accounting for 23% of 2000 to 2013 funding.
Cultivation of key public & private donor relationships, co-financing, shaping vaccine markets and mobilising civil society advocacy.
Approximately six million future deaths averted from hepatitis B, Haemophilus influenzae type B, measles, pertussis, pneumococcal disease, polio, rotavirus diarrhoea and yellow fever since Gavi's launch in 2000.
18 December 2014
A global conspiracy of health
The Washington Post
05 December 2014
Ebola Vaccines: Why Clinical Trials Are Just the First Step
The Huffington Post
04 December 2014
An Important Step in Congress for Protecting Children’s Health
02 October 2013
Laos becomes first South East Asian nation to introduce pneumococcal vaccine
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
27 March 2013
Seth Berkley on Immunization in Pakistan
Heartfile eForum Blog
05 October 2012
GAVI Alliance CEO: Leadership Is About Vision and Responsibility, Not Power
28 September 2012
Vaccines and Ensuring the Health of Children No Matter Where They Live
06 July 2012
Dagfinn Høybråten: GAVI’s mission to help fulfill MDGs
14 June 2012
How vaccination can stop 1.7m children dying this year
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2014
modal window here